Findata ā Finnish Social and Health Data Permit Authority has published its annual review of 2024. Here are some highlights:
š¢ In 2024, Findata turned 5 [ā¦]
Last week, we had the pleasure of hosting a mingle for the life science industry, bringing together colleagues, partners, and new faces for an evening of great conversations and shared inspiration.
A big thank you to everyone who joined us!
Events like [ā¦]
We are delighted to share that the NORDSTAR manuscript āUse of high-dose inhaled corticosteroids and risk of corticosteroid relatedĀ adverse events in asthma- findings from the NORDSTAR cohortā is now available online, co-authored by Quantifyās Patrik Sandin, Alexandra Cooper, Olivia [ā¦]
Havenāt yet RSVPād? Itās not too late ā click here
As the volume of literature grows exponentially, regular review and synthesis of evidence from diverse sources is crucial for informed decision-making. Choosing the right database can significantly impact the quality and relevance [ā¦]
Here are some of the things that makes our data unique:
1ļøā£Fast access to comprehensive data
The average time to fully process applications at The Danish Health Data Authority ( [ā¦]
We would like to introduce our latest addition to the Finland team: Olli-Tuomas Kovalainen!
Tuomas holds a research masterās in Economics from the University of Helsinki and has been working with Finnish health data [ā¦]
Quantifyās own BĆ©ranger Lueza and Abraham Choong are onsite at the World Evidence, Pricing and Access Congress in Amsterdam. The team has spent a busy [ā¦]
The decision timelines for Nordic HTA agencies vary depending on the agency and submission process. In Sweden, TandvĆ„rds- och lƤkemedelsfƶrmĆ„nsverket, TLVāresponsible for the reimbursement system of outpatient medicinesĀ āhas a maximum processing time of 180 [ā¦]
Amsterdamās elevation is -2 meters! The Quantify Research has been training at altitude for this yearās World Evidence, Pricing and Access [ā¦]